FdaApplication
BLA 761298
Identifiers
- fda_app_no: BLA761298
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2024-08-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAVBLU | AFLIBERCEPT-AYYH | 2MG/0.05ML | Injection |
| PAVBLU | — | 2MG/0.05ML | Injection |
2 products